itraconazole has been researched along with Ear Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilar, CR; Araújo, MG; Cirilo, NS; Guedes, ACM; Santos, SNMBD | 1 |
Bulut, Y; Günday, E; Güven, M; Yenişehirli, G | 1 |
Kurdina, MI | 1 |
Arikan, S; Karaarslan, A; Ozcan, KM; Ozcan, M | 1 |
Kaya, AD; Kiraz, N | 1 |
5 other study(ies) available for itraconazole and Ear Diseases
Article | Year |
---|---|
Lobomycosis: a therapeutic challenge.
Topics: Adult; Antifungal Agents; Biopsy; Clofazimine; Cryotherapy; Diagnosis, Differential; Ear Diseases; Humans; Itraconazole; Keloid; Lobomycosis; Male; Treatment Outcome | 2018 |
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Candidiasis; Colony Count, Microbial; Ear Diseases; Fluconazole; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
[The problem of otomycosis treatment].
Topics: Adult; Aged; Antifungal Agents; Capsules; Clotrimazole; Ear Diseases; Econazole; Female; Humans; In Vitro Techniques; Itraconazole; Miconazole; Middle Aged; Ointments; Pulse Therapy, Drug | 2003 |
In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis.
Topics: Antifungal Agents; Aspergillus; Ear Canal; Ear Diseases; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine | 2004 |
In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear Diseases; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |